期刊文献+

子宫肌瘤患者血清、瘤组织中IGFBP-3的表达变化及意义 被引量:1

Change and significance of IGFBP-3 in serum and leiomyoma tissue of patients with uterine leiomyoma
下载PDF
导出
摘要 目的观察子宫肌瘤患者血清及瘤组织中胰岛素样生长因子结合蛋白-3(IGFBP-3)的表达变化。方法采用ELISA法检测60例子宫肌瘤患者与60例正常妇女血清IGFBP-3,用免疫组化法检测上述60例子宫肌瘤患者子宫肌层和子宫肌瘤组织中的IGFBP-3。结果子宫肌瘤患者血清IGFBP-3水平低于正常妇女,IGFBP-3在子宫肌瘤组织中的表达较正常子宫肌层中的表达减低,P均<0.01。结论子宫肌瘤患者血清及瘤组织中IGFBP-3表达均降低,可能与子宫肌瘤的发生、发展有关。 Objective To detect the change of insulln-like growth factor binding protein-3 (IGFBP-3) in serum and leiomyoma tissue of patients with uterine leiomyoma. Methods The serum IGFBP-3 from 60 cases of uterine leiomyoma and 60 cases healthy women was tested by ELISA,the IGFBP-3 leiomyoma tissue and myometrium tissue from the 60 cases uterine leiomyoma was tested by immunohistochemistry. Results In patients with uterine leiomyoma, the serum IGFBP-3 was significantly lower than that in healthy women, the IGFBP-3 in leiomyoma tissue was significantly weaker than that of normal myometrium, P 〈0.01. Conclusion The IGFBP-3 in both serum and leiomyoma tissue are lower in patients with uterine leiomyoma, which suggests that IGFBP-3 play important role in the occurrence, development of uterine leiomyoma.
机构地区 北海市人民医院
出处 《山东医药》 CAS 北大核心 2009年第26期12-13,共2页 Shandong Medical Journal
基金 广西壮族自治区卫生厅计划课题基金资助项目(Z2006003)
关键词 胰岛素样生长因子 胰岛素样生长因子结合蛋白 子宫肌瘤 insulin-like growth factor insulin-like growth factor hindlng protein uterine leimyoma
  • 相关文献

参考文献2

二级参考文献29

  • 1Ghigo E, Arvat E, Gianotti L, et. al. Hypothalamic growth hormone -insulin - like growth factor - I axis across the human life span. J Pediatr Endocrinol Metab. 2000; 13 Suppl 61493 -502.
  • 2Veldhuis JD. Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender. Growth Horm IGF Res,1998,8 Suppl B:49 -59.
  • 3Shah N, Evans WS, Bowers CY. Oral. estradiol administration modulates continuous intravenous growth hormone (GH) -releasing peptide-2 -driven GH secretion in postmenopausal women. J Clin Endocrinol Metab ,2000,85 ( 8 ) :2649 - 2659.
  • 4Wu X, Sallinen K, Zhou S. Androgen excess contributes to altered growth hormone/insulin - like growth factor - 1 axis in nonobese women with polycystic ovary syndrome. Fertil Steril,2000,73(4) :730- 734.
  • 5Yilmaz MD, Hosal AS, Oguz H, et al. The effects of tonsillectomy and adenoidectomy on serum IGF - I and IGFBI?'3 levels in children. Laryngoscope ,2002,112 ( 5 ) :922 - 925.
  • 6Orio F Jr, Palomba S, Colao A,et al. GH release after GHRH plus arginine administration, in obese and overweight women with polycystic ovary syndrome. J Endocrinol Invest,2003,26 (2) : 117 - 122.
  • 7Laban C, Bustin SA, Jenkins PJ. The GH - IGF - I axis and breastcancer. Trends Endocrinol Metab,2003,14( 1 ) :28 - 34.
  • 8Bustin SA, Jenkins PJ. The growth hormone - insulin - like growthfactor-I axis and colorectal cancer. Trends Mol Med,2001,7 (10)..447 - 454.
  • 9Deitel K, Dantzer D, Ferguson P,et al. Reduced growth of human sar-coma xenografts in h-sts homozygous for the lit mutation. J Surg 0n-col,2002,81 (2) :75 -79.
  • 10Sugimoto T, Kaji H, Nakaoka D,et al. Effect of low - dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis. Eur J Endocrinol,2002,147 ( 3 ):339 - 348.

共引文献6

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部